Structure Optimization of Gatastatin for the Development of γ-Tubulin-Specific Inhibitor

Abstract

Gatastatin (<i>O</i> ⁷-benzyl glaziovianin A) is a γ-tubulin-specific inhibitor that is used to investigate γ-tubulin function in cells. We have previously reported that the unsubstituted phenyl ring of the <i>O</i> ⁷-benzyl group in gatastatin is important for γ-tubulin inhibition. To obtain further structural information regarding γ-tubulin inhibition, we synthesized several gatastatin derivatives containing a fixed <i>O</i> ⁷-benzyl moiety. Modifications of the B-ring resulted in drastic decrease in cytotoxicity, abnormal spindle formation activity, and inhibition of microtubule (MT) nucleation. In contrast, various <i>O</i> ⁶-alkylated gatastatin derivatives showed potent cytotoxicity, induced abnormal spindle formation, and inhibited MT nucleation. We had previously reported that <i>O</i> ⁶-benzyl glaziovianin A is a potent α/β-tubulin inhibitor; thus, these new results suggest that the <i>O</i> ⁶-position restricts affinity for α/β- and γ-tubulin. Considering that an <i>O</i> ⁷-benzyl group increases specificity for γ-tubulin, more potent and specific γ-tubulin inhibitors can be generated through <i>O</i> ⁶-modifications of gatastatin.